BAXTER INTERNATIONAL INC (BAX) Stock Overview
USA - NYSE:BAX - US0718131099 - Common Stock
BAX Key Statistics, Chart & Performance
The current stock price of BAX is 23.02 USD. In the past month the price decreased by -3.48%. In the past year, price decreased by -40.19%.
BAX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.76 | 236.77B | ||
| ISRG | INTUITIVE SURGICAL INC | 54.5 | 157.27B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.57 | 144.96B | ||
| SYK | STRYKER CORP | 29.33 | 144.07B | ||
| MDT | MEDTRONIC PLC | 17.19 | 121.96B | ||
| BDX | BECTON DICKINSON AND CO | 13.11 | 53.61B | ||
| IDXX | IDEXX LABORATORIES INC | 54.63 | 52.49B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.95 | 43.69B | ||
| RMD | RESMED INC | 28.61 | 40.00B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.08 | 34.20B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.62 | 27.05B | ||
| DXCM | DEXCOM INC | 39.68 | 26.45B |
Related stock screener links
About BAX
Company Profile
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. The company is headquartered in Deerfield, Illinois and currently employs 38,000 full-time employees. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. The company provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Company Info
BAXTER INTERNATIONAL INC
One Baxter Parkway
Deerfield ILLINOIS 60015 US
CEO: Jose E. Almeida
Employees: 38000
Phone: 12249482000
BAXTER INTERNATIONAL INC / BAX FAQ
What is the stock price of BAXTER INTERNATIONAL INC today?
The current stock price of BAX is 23.02 USD. The price decreased by -2.83% in the last trading session.
What is the ticker symbol for BAXTER INTERNATIONAL INC stock?
The exchange symbol of BAXTER INTERNATIONAL INC is BAX and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is BAX stock listed?
BAX stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for BAXTER INTERNATIONAL INC stock?
22 analysts have analysed BAX and the average price target is 29.98 USD. This implies a price increase of 30.23% is expected in the next year compared to the current price of 23.02. Check the BAXTER INTERNATIONAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BAXTER INTERNATIONAL INC worth?
BAXTER INTERNATIONAL INC (BAX) has a market capitalization of 11.82B USD. This makes BAX a Large Cap stock.
How many employees does BAXTER INTERNATIONAL INC have?
BAXTER INTERNATIONAL INC (BAX) currently has 38000 employees.
What are the support and resistance levels for BAXTER INTERNATIONAL INC (BAX) stock?
BAXTER INTERNATIONAL INC (BAX) has a resistance level at 23.68. Check the full technical report for a detailed analysis of BAX support and resistance levels.
Is BAXTER INTERNATIONAL INC (BAX) expected to grow?
The Revenue of BAXTER INTERNATIONAL INC (BAX) is expected to grow by 7.11% in the next year. Check the estimates tab for more information on the BAX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BAXTER INTERNATIONAL INC (BAX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BAX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BAX, evaluating the profitability, health, valuation and growth aspects
- BAXTER INTERNATIONAL INC (BAX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BAXTER INTERNATIONAL INC (BAX) Sales and EPS estimates to see what analysts future expectations are.
- BAXTER INTERNATIONAL INC (BAX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BAXTER INTERNATIONAL INC (BAX) Insider and Institutional Ownership to learn about the owners and their transactions.
- BAXTER INTERNATIONAL INC (BAX) Stock Chart to make your own analysis
- BAXTER INTERNATIONAL INC (BAX) Latest news and press-releases to stay up to date.
Does BAXTER INTERNATIONAL INC (BAX) stock pay dividends?
BAXTER INTERNATIONAL INC (BAX) has a dividend yield of 2.87%. The yearly dividend amount is currently 1.16. Check the full fundamental report for a detailed analysis of BAX dividend history, reliability and sustainability.
When does BAXTER INTERNATIONAL INC (BAX) report earnings?
BAXTER INTERNATIONAL INC (BAX) will report earnings on 2025-11-06, before the market open.
What is the Price/Earnings (PE) ratio of BAXTER INTERNATIONAL INC (BAX)?
The PE ratio for BAXTER INTERNATIONAL INC (BAX) is 9.13. This is based on the reported non-GAAP earnings per share of 2.52 and the current share price of 23.02 USD. Check the full fundamental report for a full analysis of the valuation metrics for BAX.
What is the Short Interest ratio of BAXTER INTERNATIONAL INC (BAX) stock?
The outstanding short interest for BAXTER INTERNATIONAL INC (BAX) is 4.54% of its float. Check the ownership tab for more information on the BAX short interest.
BAX Technical Analysis
BAX Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to BAX. BAX has an average financial health and profitability rating.
BAX Financial Highlights
Over the last trailing twelve months BAX reported a non-GAAP Earnings per Share(EPS) of 2.52. The EPS decreased by -12.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.74% | ||
| ROE | -2.12% | ||
| Debt/Equity | 1.3 |
BAX Forecast & Estimates
22 analysts have analysed BAX and the average price target is 29.98 USD. This implies a price increase of 30.23% is expected in the next year compared to the current price of 23.02.
For the next year, analysts expect an EPS growth of -9.02% and a revenue growth 7.11% for BAX